Mycobacterium tuberculosis Gyrase Inhibitors as a New Class of Antitubercular Drugs

One way to speed up the TB drug discovery process is to search for antitubercular activity among compound series that already possess some of the key properties needed in anti-infective drug discovery, such as whole-cell activity and oral absorption. Here, we present MGIs, a new series of Mycobacter...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Blanco, Delia, Perez-Herran, Esther, Cacho, Mónica, Ballell, Lluís, Castro, Julia, González del Río, Rubén, Lavandera, José Luis, Remuiñán, Modesto J., Richards, Cindy, Rullas, Joaquin, Vázquez-Muñiz, María Jesús, Woldu, Ermias, Zapatero-González, María Cleofé, Angulo-Barturen, Iñigo, Mendoza, Alfonso, Barros, David
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2015
Assuntos:
Mechanisms of Action: Physiological Effects
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4356839/
https://ncbi.nlm.nih.gov/pubmed/25583730
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03913-14
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados